Emerging leader nomination and contest

The 2011 International BIO Convention is around the corner for the team at Fierce. Not only does it start in less than three weeks, but it's also being held a few short blocks from Fierce HQ at the Washington Convention Center. We're also proud that John Carroll, FierceBiotech editor-in-chief, is a co-chair of this year's program committee.

To celebrate our close collaboration with BIO, we're holding an Emerging Leaders nomination contest. The lucky winner gets complimentary access to the following:

  • BIO's one-and-a-half day Emerging Leaders Workshop (more info here)
  • FierceBiotech's Best App in Town executive breakfast (more info here)
  • Access to the BIO Exhibition

Think of the emerging leaders in your organization. Then click here and take three minutes to nominate them. (Mid-level product and marketing managers with two to five years of experience are an ideal target.)

Competition is aggressive and evolving regulatory pressures require future drug development leaders to posses a dynamic mix of logistical and strategic knowledge. New product commercialization is a critical skill, which is why we're extending this contest to the future leaders of this industry reading FierceBiotech today.

Winners will be announced late next week. Hurry, nomination deadline is this Friday, June 10. - Arsalan Arif (twitter | email)

Suggested Articles

Combining inhibitors of KRAS-G12C, mTOR and IGF1R can significantly shrink lung tumors in mice and human cancer cells, a study found.

X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, who founded the company alongside CEO Paula Ragan and biotech luminary Henri Termeer.

Henlius Biotech missed the $477 million goal it set for its IPO, but still made the top five biopharma IPOs this year with its $410 million listing.